Jeffrey M. Fryer - 19 Jan 2021 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Chief Financial Officer & Treasurer
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
19 Jan 2021
Net transactions value
+$12,180
Form type
4
Filing time
21 Jan 2022, 17:22:38 UTC
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLYB Common Stock Purchase $12,180 +1,400 +3.3% $8.70 44,048 19 Jan 2022 See Footnote F1, F2
holding RLYB Common Stock 272,609 19 Jan 2021 See Footnote F3
holding RLYB Common Stock 201,934 19 Jan 2021 See Footnote F4
holding RLYB Common Stock 201,934 19 Jan 2021 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $9.00, inclusive. The reporting person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 Shares of common stock are held in a Roth IRA.
F3 Shares of common stock are held in a revocable trust for which Mr. Fryer is the grantor.
F4 Shares of common stock are held in an irrevocable trust for the benefit of one of Mr. Fryer's children. Mr. Fryer disclaims beneficial ownership of such shares.
F5 Shares of common stock are held in an irrevocable trust for the benefit of one of Mr. Fryer's children. Mr. Fryer disclaims beneficial ownership of such shares.

Remarks:

Chief Financial Officer & Treasurer